期刊文献+

HBV感染自然史研究进展 被引量:9

Advance in the natural history of hepatitis B virus infection
原文传递
导出
摘要 病毒复制与宿主免疫之间的动态平衡在HBV感染自然史进展和发病机制中起重要作用。多数免疫能力正常的成人感染HBV后呈自限性,而在婴幼儿则多发展成为慢性HBV感染。慢性HBV感染分为4期:免疫耐受期、HBeAg阳性慢性肝炎期、非复制的HBsAg携带期和HBeAg阴性慢性肝炎期。HBV DNA水平、HBeAg的状态以及ALT水平可以预测HBV感染的长期结局如肝硬化或肝细胞癌。本文对HBV感染自然史分期、慢性HBV感染的结局和预后进行了综述。 The dynamic balance between viral replication and the host immune response plays a key role in the natural history and pathogenesis of hepatitis B virus infection. Most infections in immunocompetent adults are self-limited, whereas most infants develop chronic HBV infection. Chronic HBV infection may present in four phases: immune toler- ance, HBeAg-positive chronic hepatitis, non-replicative HBsAg carriers and HBeAg-negative chronic hepatitis. Several risk factors, such as HBV DNA levels, HBeAg status, and ALT levels, have been identified to predict the long-term out-come, including cirrhosis and HCC. Stages of the natural history of HBV infection, outcome and prognosis of chronic HBV infection are reviewed in this paper.
出处 《中国病原生物学杂志》 CSCD 2009年第5期374-377,共4页 Journal of Pathogen Biology
基金 北京市自然科学基金资助项目(No.5062019)
关键词 HBV感染 分期 自然史 综述 Hepatitis B virus infection staging natural history, review
  • 相关文献

参考文献37

  • 1Oeama P,Opio CK, Lee WM. Hepatitis B virus infection: current status[J]. Am J Med,2005,118(12):1413.
  • 2Mast EE,Williams IT,Alter MJ,et al. Hepatitis B vaccination of adolescent and adult high-risk groups in the United States[J].Vaccine, 1998,16 :S27 - S29.
  • 3McMahon BJ,Alward WL, Hall DB,et al. Acute hepatitis B virus infection:relation of age to the clinical expression of disease and subsequent development of the carrier state[J]. J Infect Dis, 1985,151 : 599- 603.
  • 4Wright TL,Mamish D,Combs C,et al. Hepatitis B virus and apparent fulminant non-A, non-B hepatitis[J]. Lancet, 1992,339: 952-955.
  • 5Ganem D,Prince AM. Hepatitis B virus infection-natural history and clinical consequences[J]. N Engl J Med, 2004,350: 1118- 1129.
  • 6Vassiliadis T, Garipidou V, Tziomalos K, et al. Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy-a prospective case series[J]. Am J Hematol, 2005,80:197- 203.
  • 7Yuki N, Nagaoka T, Yamashiro M, et al. Long-term histologic and virologie outcomes of acute self-limited hepatitis B[J]. Hepatology,2003,37 : 1172- 1179.
  • 8Marusawa H,Uemoto S,Hijikata M,et al. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen[J]. Hepatol, 2000,31 : 488- 495.
  • 9Pungpapong S,Kim WR,Poterucha JJ. Natural history of hepatitis B virus infection:an update for clinicians[J]. Mayo Clin Proc, 2007,82:967-975.
  • 10Chen M,Sallberg M, Hughes J,et al. Immune tolerance split between hepatitis B vims preeore and core proteins[J]. J Virol, 2005,79:3016-3027.

同被引文献94

引证文献9

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部